CSR Program: The Global Fund | Takeda Pharmaceuticals

After years of remarkable progress, increasing drug resistance and funding shortfalls have slowed the fight against HIV, TB and malaria. The Takeda Initiative is a 15-year partnership with the Global Fund. Launched in 2010, our first phase* boosted malaria prevention in Tanzania with the distribution of mosquito nets, accelerated access to TB treatment in Kenya, and expanded HIV services and awareness in Nigeria. Starting in 2020, we are focusing on improving maternal and child health and supporting efforts to achieve Universal Health Coverage by integrating quality HIV, TB and malaria services in antenatal and postnatal care in several priority countries in Africa.

*About Takeda Initiative 1

Biography: Peter Sands is executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Previously, he was CEO of Standard Chartered and before that Director at McKinsey & Co. in London. He has been Senior Fellow at the Harvard John F. Kennedy School of Government and Lead Non-Executive Board Director of the United Kingdom’s Department of Health. He served on many other boards and commissions, such as Governor of the National Institute of Economic and Social Research, and Chairman of the Regulation Committee of the Institute of International Finance.